NCT00551421 Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00551213 A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) Status COMPLETED Phase PHASE2
NCT00545545 Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00544362 Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT00544349 Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00541112 Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery Status TERMINATED Phase PHASE2
NCT00540943 Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00538291 Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment Status TERMINATED Phase PHASE2
NCT00537823 Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement Status TERMINATED Phase PHASE2
NCT00533949 High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE3
NCT00524017 Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract Status COMPLETED Phase PHASE2
NCT00522665 Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00519831 Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC Status TERMINATED Phase PHASE2
NCT00513266 Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery Status UNKNOWN Phase PHASE2
NCT00509561 Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer Status UNKNOWN Phase PHASE2/PHASE3